Cargando…
New agents approved for treatment of acute staphylococcal skin infections
Vancomycin has been a predominant treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections for decades. However, growing reservations about its efficacy led to an urgent need for new antibiotics effective against MRSA and other drug-resistant Staphylococcus aureus strains. This re...
Autores principales: | Tatarkiewicz, Jan, Staniszewska, Anna, Bujalska-Zadrożny, Magdalena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5108382/ https://www.ncbi.nlm.nih.gov/pubmed/27904526 http://dx.doi.org/10.5114/aoms.2016.59838 |
Ejemplares similares
-
New antihistamines – perspectives in the treatment of some allergic and inflammatory disorders
por: Tatarkiewicz, Jan, et al.
Publicado: (2018) -
(68)Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership
por: Carlucci, Giuseppe, et al.
Publicado: (2021) -
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2019
por: Rameau, Anais, et al.
Publicado: (2020) -
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review 2020
por: Brenner, Michael J., et al.
Publicado: (2021) -
New Medical Device and Therapeutic Approvals in Otolaryngology: State of the Art Review of 2021
por: Choi, Alexander M., et al.
Publicado: (2022)